Argos Therapeutics (FRA:77AA) Scaled Net Operating Assets : -0.12 (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Argos Therapeutics's operating assets for the quarter that ended in Sep. 2018 was €2.52 Mil. Argos Therapeutics's operating liabilities for the quarter that ended in Sep. 2018 was €4.26 Mil. Argos Therapeutics's Total Assets for the quarter that ended in Jun. 2018 was €14.37 Mil. Therefore, Argos Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2018 was -0.12.

Argos Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Argos Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Scaled Net Operating Assets Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Scaled Net Operating Assets

Get a 7-Day Free Trial

-7.20

-0.04

-0.05

-0.23

-0.05

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.25	-0.19	-0.05	-0.06	-0.12

Competitive Comparison of Argos Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Argos Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argos Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argos Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Argos Therapeutics's Scaled Net Operating Assets falls into.

Argos Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Argos Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2017 )
=	(Operating Assets (A: Dec. 2017 )	-	Operating Liabilities (A: Dec. 2017 ))	/	Total Assets (A: Dec. 2016 )
=	(4.722	-	8.919)	/	92.149
=	-0.05

where

	Operating Assets		(A: Dec. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	17.557	-	12.835
=	4.722

	Operating Liabilities		(A: Dec. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	25.36	-	10.253	-	6.188
=	8.919

Argos Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2018 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2018 )
=	(Operating Assets (Q: Sep. 2018 )	-	Operating Liabilities (Q: Sep. 2018 ))	/	Total Assets (Q: Jun. 2018 )
=	(2.52	-	4.258)	/	14.371
=	-0.12

where

	Operating Assets		(Q: Sep. 2018 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	9.325	-	6.805
=	2.52

	Operating Liabilities		(Q: Sep. 2018 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	20.1	-	10.252	-	5.59
=	4.258

Argos Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines